This is a routine, non-material amendment to comply with SEC disclosure rules. Traders should focus on the company's ongoing merger with The Doctors Company and its financial performance, not this filing. The lack of financial changes or restatements is a positive signal, but the amendment itself does not alter the company's fundamentals.
Price Chart
Executive Summary
ProAssurance filed an amended 10-K/A to include Part III disclosures (directors, executive compensation, related parties, and auditor fees) that were omitted from the original filing. The amendment was required because the company could not file its definitive proxy statement within 120 days of its fiscal year-end. The filing confirms no restatements, no financial statement corrections, and no changes to previously reported financials. The company continues to pursue a merger with The Doctors Company, expected to close by June 30, 2026.
Key Facts
- Amendment was filed to include Part III disclosures (Items 10-14) that were omitted from the original 10-K.
- No financial statements were included or amended; no restatements or corrections to prior financials.
- The amendment was required because the company could not file its definitive proxy statement within 120 days of its fiscal year-end.
- The company continues to anticipate closing its merger with The Doctors Company by June 30, 2026.
- The company's auditor, Ernst & Young, remains unchanged.
Financial Impact
No financial impact; the amendment is purely procedural and informational.
Risk Factors
- The merger with The Doctors Company is subject to regulatory approval and may not close as expected.
- The company's financial performance in 2025, while improved, is still subject to the risks of the insurance industry, such as claims severity and reserve development.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001127703-26-000013 |
| Document: pra-20251231x10xkaex311.htm | 0001127703-26-000013 |
| Document: pra-20251231x10xkaex312.htm | 0001127703-26-000013 |
| Document: 0001127703-26-000013-index-headers.html | 0001127703-26-000013 |
| Document: 0001127703-26-000013-index.html | 0001127703-26-000013 |
| Document: 0001127703-26-000013.txt | 0001127703-26-000013 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 6, 2026 12w ago | 15-12G | $25.00 awaiting T+20 | awaiting T+20 | — | $22.12 (−11.52%) |
Jun 26, 2026 14w ago | 25-NSE | $24.99 awaiting T+20 | awaiting T+20 | — | $22.12 (−11.48%) |
Jun 26, 2026 14w ago | 8-K | $24.99 awaiting T+20 | awaiting T+20 | — | $22.12 (−11.48%) |
Jun 2, 2026 17w ago | 8-K | $24.42 $25.00 | ▲ +2.38% | ▲ +3.37% | $22.12 (−9.42%) |
Apr 8, 2026 25w ago | 10-K/A | $24.26 $24.60 | ▲ +1.40% | ▼ −6.17% | $22.12 (−8.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access